Ftse Mib
33.675,15
1,37%
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
NASDAQ
17.721,59
-0,79%
Bitcoin
64.874,27
0,08%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Summit Therapeutics Inc (SMMT) Summit Therapeutics Inc (SMMT) Notizie

Summit Therapeutics Inc

SMMT
7,79
-0,15 (-1,89%)
21 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/6/202423:14EDGAR2Form D - Notice of Exempt Offering of Securities
17/6/202423:25EDGAR2Form 8-K - Current report
13/6/202420:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/6/202412:18EDGAR2Form 8-K - Current report
03/6/202412:05EDGAR2Form 8-K - Current report
03/6/202411:30BWSummit Raises $200 Million; Also Expands License Territories..
01/6/202414:00BWIvonescimab Manuscript for HARMONi-A Clinical Trial Results..
01/6/202401:00BW Ivonescimab in Combination with Chemotherapy Approved in..
31/5/202400:00BWSummit Therapeutics Reports Inducement Grants Under Nasdaq..
30/5/202422:48EDGAR2Form 8-K - Current report
30/5/202420:29BWIvonescimab Monotherapy Decisively Beats Pembrolizumab..
24/5/202414:35EDGAR2Form 8-K - Current report
13/5/202414:03EDGAR2Form 8-K - Current report
13/5/202413:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/5/202413:00BWSummit Therapeutics Reports Financial Results and..
24/4/202422:30BWSummit Therapeutics to Host First Quarter 2024 Financial..
11/4/202422:30BWSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned..
10/4/202413:00BWSummit Therapeutics to Present at the Stifel 2024 Targeted..
22/3/202412:00BWPromising Intracranial Anti-Tumor Activity and Safety Data..
14/3/202412:00BWIntracranial Anti-Tumor Activity and Safety of Ivonescimab..
05/3/202422:05EDGAR2Form 8-K - Current report
05/3/202413:00BWSummit Therapeutics to Present at the Barclays 26th Annual..
20/2/202414:05EDGAR2Form 8-K - Current report
20/2/202413:55EDGAR2Form S-3 - Registration statement under Securities Act of..
20/2/202413:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202413:00BWSummit Therapeutics Reports Financial Results and..
15/2/202423:25EDGAR2Form 8-K - Current report
14/2/202416:29BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023..
14/2/202413:00BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023
07/2/202413:00BWSummit Therapeutics to Present at Oppenheimer’s 34th Annual..
08/1/202415:07EDGAR2Form 8-K - Current report
08/1/202415:00BWSummit Therapeutics Announces Updated Phase II Data for..
04/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:06EDGAR2Form 8-K - Current report
03/1/202413:30BWSummit Therapeutics to Present at the 42nd Annual J.P...
13/12/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202314:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202314:03EDGAR2Form 8-K - Current report
07/11/202313:00BWSummit Therapeutics Reports Financial Results and..
02/11/202321:41BWLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins..
31/10/202321:02EDGAR2Form 8-K - Current report
31/10/202313:00BWIvonescimab’s Novel Mechanism of Action Highlighting..
26/10/202314:00BWSummit Therapeutics to Host Q3 2023 Financial Results &..
19/10/202314:00BWH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert,..
16/10/202313:46EDGAR2Form 8-K - Current report
16/10/202313:00BWSummit Therapeutics Appoints Proven Biotech Leader Manmeet..
19/9/202321:40EDGAR2Form DEF 14A - Other definitive proxy statements
08/9/202322:08EDGAR2Form PRE 14A - Other preliminary proxy statements
Apertura: 7,94 Min: 7,73 Max: 8,22
Chiusura: 7,94

La tua Cronologia

NASDAQ
SMMT
Summit Therapeutics
BOV
BIOM3
BIOMM ON
BIT
AGP
Altea Green Power
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network